New medical staff in the post-COVID-19 period entailed altered quality of antibiotic therapy - 31/08/24
, Nathalie Challut c, Marc-Antoine Hennet d, Arnaud Lemasson e, Diane Lesselingue f
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | The COVID-19 pandemic was characterized by medical staff wishing to discontinue hospital practice. |
• | Hospitals are likely to have been responsible for a significant rise of antibiotic consumption after the pandemic. |
• | New medical staff compared to former medical staff were less likely to request advice on infectious disease. |
• | New medical staff were associated with a heightened rate of unnecessary antibiotic therapy. |
• | Crises in hospitals and changes in medical staff necessitate dedicated antimicrobial stewardship. |
Abstract |
Objective |
Our aim was to audit antibiotic prescriptions from renewed medical staff.
Methods |
A retrospective multicenter audit of antibiotic therapies was performed in four institutions with similar antimicrobial stewardship programs. We compared antibiotic prescriptions from physicians practicing before and after the pandemic. Antibiotic prescriptions were classified as optimal (OAT), suboptimal (SAT) or unnecessary antibiotic therapy (UAT).
Results |
All in all, 165 antibiotic courses was audited in 2023: OAT, SAT and UAT rates were 21, 42 and 38% respectively. Sixty-seven out of 165 (41%) prescriptions were given by new physicians. In multivariate analysis, antibiotic prescriptions from the latter compared to former were associated with less diagnosis of infection written in patient charts: AOR [CI 95%] 3.68 [1.53–8.83], and with UAT: 2.76 [1.34–5.68].
Conclusions |
Ensuring adequate antibiotic prescriptions with renewed medical staff requires a high level of education and training.
Le texte complet de cet article est disponible en PDF.Keywords : Antimicrobial stewardship, Antibiotic consumption, Audit, Educational resources, Medical staff
Plan
Vol 54 - N° 6
Article 104957- septembre 2024 Retour au numéro
Article précédent
- Voriconazole as an alternative oral treatment in fluconazole-resistant urinary candidiasis
- Christelle Boglione-Kerrien, Audrey Le Bot, David Luque Paz, Marie-Clémence Verdier, Hélène Guegan, Jean-Pierre Gangneux, Eric Bellissant, Florian Lemaitre
- Discussion on ‘External validation of two clinical prediction models for mortality in COVID-19 patients (4C and NEWS2), in three centers in Medellín, Colombia: Assessing the impact of vaccination over time’
- Hai-Feng Liu, Hong-Min Fu
Bienvenue sur EM-consulte, la référence des professionnels de santé.